TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,290,000 | -24.1% | 315,237 | 0.0% | 0.06% | -31.5% |
| Q2 2020 | $5,649,000 | +13.1% | 315,237 | -27.5% | 0.09% | -29.2% |
| Q1 2020 | $4,994,000 | +41.0% | 435,000 | 0.0% | 0.13% | +85.7% |
| Q4 2019 | $3,541,000 | -17.9% | 435,000 | 0.0% | 0.07% | -39.7% |
| Q3 2019 | $4,311,000 | -21.5% | 435,000 | 0.0% | 0.12% | -7.9% |
| Q2 2019 | $5,494,000 | +23.9% | 435,000 | 0.0% | 0.13% | +0.8% |
| Q1 2019 | $4,433,000 | +40.0% | 435,000 | 0.0% | 0.12% | +3.3% |
| Q4 2018 | $3,167,000 | -36.7% | 435,000 | -13.0% | 0.12% | -9.7% |
| Q3 2018 | $5,000,000 | -20.9% | 500,000 | 0.0% | 0.13% | -19.3% |
| Q2 2018 | $6,325,000 | – | 500,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |